Erisyon is commercializing the world's first single-molecule protein sequencer, utilizing fluorosequencing technology to achieve single-molecule resolution and absolute quantification of protein abundance. This innovation enables earlier detection and more effective treatment of diseases by facilitating billions of simultaneous experiments with unparalleled sensitivity and fidelity.
Funding
Funding not disclosed
Founders
Product
Problem
Current protein sequencing methods lack the sensitivity to detect low-abundance proteins and struggle with complex mixtures, hindering early disease detection and personalized medicine. Existing technologies often require large sample volumes and extensive sample preparation, limiting their applicability in clinical settings.
Solution
Erisyon is developing a single-molecule protein sequencer based on fluorosequencing technology, enabling direct and absolute quantification of proteins at unprecedented sensitivity. This approach allows for billions of simultaneous experiments, providing a comprehensive view of the proteome even from limited samples. By achieving single-molecule resolution, Erisyon's technology can identify and quantify proteins that are currently undetectable, facilitating earlier disease detection, improved diagnostics, and more effective treatment strategies. The platform aims to bring the advantages of next-generation DNA sequencing to the field of proteomics.
Target Audience
The primary target audience includes researchers in proteomics, drug discovery, and diagnostics, as well as clinicians seeking more sensitive and accurate tools for disease detection and personalized medicine.
Features
- Single-molecule resolution for detecting low-abundance proteins
- Massively parallel architecture enabling billions of simultaneous experiments
- Absolute quantification of protein abundance without amplification biases
- Direct sequencing of proteins without the need for antibodies or labels
- Potential for high-throughput analysis of complex protein mixtures
- Technology based on fluorosequencing invented at the University of Texas Austin